Geneos Wealth Management Inc. Amneal Pharmaceuticals, Inc. Transaction History
Geneos Wealth Management Inc.
- $3.92 Billion
- Q2 2025
A detailed history of Geneos Wealth Management Inc. transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 68 shares of AMRX stock, worth $663. This represents 0.0% of its overall portfolio holdings.
Number of Shares
68Holding current value
$663% of portfolio
0.0%Shares
8 transactions
Others Institutions Holding AMRX
# of Institutions
248Shares Held
145MCall Options Held
194KPut Options Held
49.3K-
Vanguard Group Inc Valley Forge, PA17.6MShares$171 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$120 Million6.02% of portfolio
-
Rubric Capital Management LP New York, NY11.7MShares$114 Million2.18% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$110 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.62MShares$54.8 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.48B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...